These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5678598)

  • 1. Relationship of the partial thromboplastin time to the Lee-White coagulation time.
    MacAulay MA; Frisch CR; Klionsky BL
    Tech Bull Regist Med Technol; 1968 Aug; 38(8):223-7. PubMed ID: 5678598
    [No Abstract]   [Full Text] [Related]  

  • 2. A modified whole blood partial thromboplastin test for the assessment of heparinization.
    Ray PK; Abbott D
    Can Med Assoc J; 1973 Jun; 108(12):1505-8. PubMed ID: 4714876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin lock-induced alterations in the activated partial thromboplastin time.
    O'Neill TJ; Tierney LM; Proulx RJ
    JAMA; 1974 Mar; 227(11):1297-8. PubMed ID: 4405979
    [No Abstract]   [Full Text] [Related]  

  • 6. The activated partial thromboplastin time in the control of heparin treatment.
    Hirsh J; O'Sullivan EF; Gallus AS; Martin M
    Australas Ann Med; 1970 Nov; 19(4):334-7. PubMed ID: 5490660
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro comparison of the thrombin time and activated partial thromboplastin time in the laboratory control of heparin therapy.
    Soloway HB; Cox SP
    Am J Clin Pathol; 1973 Nov; 60(5):648-50. PubMed ID: 4543085
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial thromboplastin time in heparin therapy.
    Burdick CO; Colman CW
    Am J Clin Pathol; 1971 Mar; 55(3):384-5. PubMed ID: 5549908
    [No Abstract]   [Full Text] [Related]  

  • 9. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated partial thromboplastin time test in heparin therapy. A study.
    Simmons A; Cross DE
    Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362
    [No Abstract]   [Full Text] [Related]  

  • 11. The activated partial thromboplastin time as a control in heparin therapy.
    Harmeling JG; Cordray DR
    South Med J; 1967 Jun; 60(6):594-8. PubMed ID: 6024630
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical comparison of the automated activated partial thromboplastin time and the clotting time in the regulation of heparin therapy.
    Colman RW; Oxley L; Giannusa P
    Am J Clin Pathol; 1970 Jun; 53(6):904-7. PubMed ID: 5504609
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of the activated partial thromboplastin time in the control of heparin administration.
    Lenaham JG; Frye S; Phillips GE
    Clin Chem; 1966 May; 12(5):263-8. PubMed ID: 5944655
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of various activated partial thromboplastin reagents in the laboratory control of heparin therapy.
    Soloway HB; Cornett BM; Grayson JW
    Am J Clin Pathol; 1973 Apr; 59(4):587-90. PubMed ID: 4692989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G; Presser HJ; Urbahn H
    Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of heparin therapy using thrombin time and activated partial thromboplastin time--a comparison].
    Osterwalder J
    Schweiz Med Wochenschr; 1987 Apr; 117(14):539-40. PubMed ID: 3576165
    [No Abstract]   [Full Text] [Related]  

  • 17. On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy.
    Teien AN; Abildgaard U
    Thromb Haemost; 1976 Jun; 35(3):592-7. PubMed ID: 989966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The laboratory control of heparin therapy.
    Estes JW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):58-65. PubMed ID: 808391
    [No Abstract]   [Full Text] [Related]  

  • 19. The PiCT
    Brisset AC; Ferrández A; Krause M; Rathbun S; Marlar R; Korte W
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of heparin therapy in thromboembolism].
    Hiller E
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1367-70. PubMed ID: 4716792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.